| Trial ID: | L4594 |
| Source ID: | NCT02344641
|
| Associated Drug: |
Exenatide
|
| Title: |
Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Heart Failure
|
| Interventions: |
DRUG: Exenatide
|
| Outcome Measures: |
Primary: The change in plasma NT-proBNP level after using exenatide for 4 weeks, 4 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
234
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2015-01
|
| Completion Date: |
2016-12
|
| Results First Posted: |
|
| Last Update Posted: |
2015-01-27
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02344641
|
